Home » Topics » BioWorld Science

BioWorld Science
RSS

Hoxb8-mutated mice develop OCD-like behavior and chronic anxiety

July 29, 2019

PARAGON-HF study of sacubitril/valsartan misses statistical significance on primary endpoint

July 29, 2019

Sanofi announces topline phase III data on Zynquista, provides notice to end Lexicon collaboration

July 29, 2019

IDMC recommends continuation of PROLONG trial of OBE-022 in preterm labor

July 29, 2019

New ketamine prodrugs presented by XW Laboratories

July 29, 2019

Sichuan Kelun-Biotech Biopharmaceutical synthesizes new antivirals

July 29, 2019

Adamed presents new MDM2 inhibitors

July 29, 2019

Seal Rock Therapeutics patents MAP3K5 inhibitors

July 29, 2019

G1 Therapeutics divulges new cyclin-dependent kinases inhibitors

July 29, 2019

Insights into frequent NSCLC mutation

July 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...